2-Ethyl-1,3-hexanediol
General Information
Mainterm | 2-Ethyl-1,3-hexanediol |
CAS Reg.No.(or other ID) | 94-96-2 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 7211 |
IUPAC Name | 2-ethylhexane-1,3-diol |
InChI | InChI=1S/C8H18O2/c1-3-5-8(10)7(4-2)6-9/h7-10H,3-6H2,1-2H3 |
InChI Key | RWLALWYNXFYRGW-UHFFFAOYSA-N |
Canonical SMILES | CCCC(C(CC)CO)O |
Molecular Formula | C8H18O2 |
Wikipedia | ethohexadiol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 146.23 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Complexity | 73.7 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A D R S g g A I C A A A A A g A A A A A A A A A A A A A A A A A A A A A A A A A A E A I A A A A A Q A A F A A A A A A G A w A A O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 40.5 |
Monoisotopic Mass | 146.131 |
Exact Mass | 146.131 |
XLogP3 | None |
XLogP3-AA | 1.3 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 10 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.8846 |
Human Intestinal Absorption | HIA+ | 0.9902 |
Caco-2 Permeability | Caco2+ | 0.6447 |
P-glycoprotein Substrate | Non-substrate | 0.5525 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9195 |
Non-inhibitor | 0.6665 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8918 |
Distribution | ||
Subcellular localization | Lysosome | 0.5139 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8561 |
CYP450 2D6 Substrate | Non-substrate | 0.8277 |
CYP450 3A4 Substrate | Non-substrate | 0.6281 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5615 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8167 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.7782 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8774 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7965 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8821 |
Non-inhibitor | 0.7172 | |
AMES Toxicity | Non AMES toxic | 0.9637 |
Carcinogens | Non-carcinogens | 0.5577 |
Fish Toxicity | Low FHMT | 0.7899 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8589 |
Honey Bee Toxicity | High HBT | 0.6794 |
Biodegradation | Ready biodegradable | 0.9226 |
Acute Oral Toxicity | III | 0.7717 |
Carcinogenicity (Three-class) | Non-required | 0.7605 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.6022 | LogS |
Caco-2 Permeability | 1.0060 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.3787 | LD50, mol/kg |
Fish Toxicity | 2.3634 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.2233 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty alcohols |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty alcohols |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty alcohol - Secondary alcohol - Organic oxygen compound - Hydrocarbon derivative - Primary alcohol - Organooxygen compound - Alcohol - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms. |
From ClassyFire